Signet Healthcare Partners Invests in Juno Pharmaceuticals Corp.
February 24, 2022
Signet Healthcare Partners, a New York-based healthcare growth equity firm, has completed a growth equity investment in Canadian specialty generics company Juno Pharmaceuticals Corp. Juno will use the proceeds to expand its complex and high-value generic and biosimilar portfolio and accelerate its growth and pipeline development in Canada and international markets.
- Buyers
- Signet Healthcare Partners
- Targets
- Juno Pharmaceuticals Corp.
- Industry
- Pharmaceuticals
- Location
- Quebec, Canada
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.